Evidence mapPaperPMID 39962142Full record

ArticleScientific reports2025

Nano-scaffold containing functional motif of stromal cell-derived factor 1 enhances neural stem cell behavior and synaptogenesis in traumatic brain injury.

Mohammad Amin Bayat Tork, Mohsen Saberifar, Hamed Joneidi Yekta, Mehrdad Hajinejad, Hassan Hosseini Ravandi, Ali Gorji, Sajad Sahab Negah

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad Amin Bayat Tork *Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohsen Saberifar *Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Hamed Joneidi Yekta *New Technologies Research Center, Amirkabir University of Technology, Tehran, Iran.
Mehrdad HajinejadQaen Faculty of Medical Science, Birjand University of Medical Sciences, Birjand, Iran.
Hassan Hosseini RavandiShefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.
Ali GorjiShefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran. gorjial@uni-muenster.de.
Sajad Sahab NegahNeuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Sahabnegahs@mums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traumatic brain injury (TBI) is a leading cause of mortality and morbidity worldwide, presenting a significant challenge due to the lack of effective therapies. Neural stem cells (NSCs) have shown promising potential in preclinical studies as a therapy for TBI. However, their application is limited by challenges related to poor survival and integration within the injured brain. This study investigated the effect of a novel nano-scaffold containing stromal cell-derived factor 1 (SDF-1) on NSC behavior and synaptogenesis after TBI. Using an innovative design, we successfully fabricated a nano-scaffold with Young's modulus of approximately 3.21 kPa, which aligns closely with the mechanical properties exhibited by neural tissue. This achievement marks the first time such a scaffold has been created and has promising implications for its potential use in neural tissue engineering applications. Our findings demonstrate that the nano-scaffold enhances NSC proliferation, migration, and differentiation capacity in vitro. Moreover, when transplanted into the injured brain, the nano-scaffold promotes the survival and integration of NSCs, leading to increased synaptogenesis and functional recovery. These findings suggest that using the novel nano-scaffold containing SDF-1 could provide a promising approach to treating TBI by improving NSC behavior and promoting synaptogenesis.

Indexed as

Brain Injuries, TraumaticChemokine CXCL12Neural Stem CellsNeurogenesisSynapsesTissue ScaffoldsAnimalsCell DifferentiationCell MovementCell ProliferationCells, CulturedMaleMiceRatsRats, Sprague-DawleyTissue EngineeringChemokine CXCL12Brain injuryCXCL12Nano-scaffoldSynaptic transmissionTissue engineering

Identifiers

PMID39962142
PMCPMC11832925

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.